Research Article
Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
Table 1
The relationship between EIF3J-AS1 and clinicopathological features in the TCGA cohort.
| Clinicopathological characteristics | Low expression | High expression | | value |
| Age | | ≤60 | 320 | 280 | 5.8 | 0.016 | >60 | 224 | 265 | Tumor size | | <2 cm | 119 | 157 | 10.29 | 0.006 | 2–5 cm | 344 | 293 | >5 cm | 80 | 93 | Lymph node metastasis | | N0 | 274 | 239 | 8.41 | 0.038 | N1 | 161 | 203 | N2 | 65 | 54 | N3 | 39 | 35 | Distant metastasis | | No | 469 | 435 | 3.68e − 29 | 1 | Yes | 11 | 11 | Clinical stage | | I-II | 406 | 398 | 0.08 | 0.78 | III-IV | 130 | 134 | Estrogen receptor | | Negative | 198 | 42 | 125.9 | <2.2e − 16 | Positive | 327 | 472 | Progesterone receptor | | Negative | 245 | 99 | 87.4 | <2.2e − 16 | Positive | 278 | 414 |
|
|